6025-68-9 Usage
General Description
Pyrrolo[1,2-a]quinoxalin-4(5H)-one, also known as PQX-1, is a chemical compound with a fused pyrroloquinoxaline ring system. It is a heterocyclic compound that has potential therapeutic applications due to its structural properties and biological activities. PQX-1 has been studied for its anti-inflammatory and anticancer properties, and it has shown promising results in inhibiting the growth of cancer cells. Additionally, PQX-1 has been investigated for its potential use as a fluorescent probe for detecting biomolecules and as a potential precursor in the synthesis of pharmaceuticals and other organic compounds. Pyrrolo[1,2-a]quinoxalin-4(5H)-one has garnered interest in the scientific community for its diverse applications and potential in drug discovery and biomedical research.
Check Digit Verification of cas no
The CAS Registry Mumber 6025-68-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,0,2 and 5 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 6025-68:
(6*6)+(5*0)+(4*2)+(3*5)+(2*6)+(1*8)=79
79 % 10 = 9
So 6025-68-9 is a valid CAS Registry Number.
6025-68-9Relevant articles and documents
Synthesis of pyrrole and indole quinoxalinone and oxazinone derivatives by intramolecular copper-catalyzed reactions
Vaillard, Victoria A.,Rossi, Roberto A.,Martin, Sandra E.
, p. 4927 - 4935 (2011/08/06)
Intramolecular N-arylation of pyrrole and indole carboxamides and carboxylates linked with a pendant haloarene by Cu-catalyzed reactions to synthesize pyrrole and indole quinoxalinone and oxazinone derivatives is reported. The ring closure reactions were carried out by conventional heating and MW irradiation. The use of conventional heating affords moderate to good yields of the quinoxalinone and oxazinone derivatives (34-72%), while by using MW heating the best results are obtained (41-99%). The Royal Society of Chemistry 2011.
Tricyclic pyrrolopyrazine 5-HT3 -active compounds
-
, (2008/06/13)
The present invention relates to a compound selected from these of formula (I): STR1 in which A and R1 are as defined in the description, and medicinal product containing the same which is useful for treating a disorder linked to the 5-HT3 receptors.
